Hood River Capital Management LLC Agios Pharmaceuticals, Inc. Transaction History

Hood River Capital Management LLC

$5.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $8.2 Million - $11.4 Million	-195,721 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $109,430 - $128,789	-2,102 Reduced 1.06%	195,721 $10.8 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $867,438 - $1.13 Million	-19,612 Reduced 9.02%	197,823 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $117,397 - $164,518	3,535 Added 1.65%	217,435 $9.42 Million
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $709,576 - $1.17 Million	-20,950 Reduced 8.92%	213,900 $7.49 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $3,858 - $5,989	112 Added 0.05%	234,850 $12.6 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $84,032 - $143,457	-2,666 Reduced 1.12%	234,738 $8.33 Million
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $521,617 - $877,281	17,341 Added 7.88%	237,404 $11.3 Million
Q3 2019 Nov 13, 2019	BUY	$32.4 - $49.58 $62,629 - $95,838	1,933 Added 0.89%	220,063 $7.13 Million
Q2 2019 Aug 13, 2019	BUY	$46.17 - $68.1 $358,002 - $528,047	7,754 Added 3.69%	218,130 $10.9 Million
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $399,090 - $588,119	-8,691 Reduced 3.97%	210,376 $14.2 Million
Q4 2018 Feb 13, 2019	BUY	$42.73 - $76.53 $3.23 Million - $5.78 Million	75,488 Added 52.58%	219,067 $10.1 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $347,671 - $446,049	4,851 Added 3.5%	143,579 $11.1 Million
Q2 2018 Jul 30, 2018	BUY	$73.22 - $99.55 $395,827 - $538,167	5,406 Added 4.05%	138,728 $11.7 Million
Q1 2018 May 07, 2018	BUY	$59.83 - $86.53 $161,840 - $234,063	2,705 Added 2.07%	133,322 $10.9 Million
Q4 2017 Feb 07, 2018	BUY	$52.12 - $72.33 $480,911 - $667,388	9,227 Added 7.6%	130,617 $7.47 Million
Q3 2017 Nov 07, 2017	BUY	$54.89 - $67.12 $6.66 Million - $8.15 Million	121,390	121,390 $8.1 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$261 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$255 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$224 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$172 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$130 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.52B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Account